Bison Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Bison Wealth's XBI Position: Q4 2024 in Review
Bison Wealth sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 3,597 shares — an estimated $355K sold.
Bison Wealth first reported a position in XBI in Q2 2020 and held it in 14 quarters. The position peaked at $355K in Q3 2024. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.
- Bison Wealth reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
- Bison Wealth sold 3,597 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $355K.
- Bison Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 14 quarters.
- Bison Wealth's State Street SPDR S&P Biotech ETF position peaked at $355K in Q3 2024.
- 738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.
Based on Bison Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.